The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

otogene.com

Founded Year

1998

Stage

Series A | Dead

About Otogene

Developer of biomedical therapeutic products that correct the underlying biological cause of hearing impairments. The company's products are to be designed to stimulate the regeneration of the cells that are essential for hearing function, thereby avoiding the need for surgery or the use of hearing aids. The company has identified gene products that impact the growth of cells within the inner ear and has developed molecules that modulate the function of these gene products. The company is also focusing on other applications for inner ear treatment, such as delivery techniques, and specialized analysis techniques.

Otogene Headquarter Location

Vor dem Kreuzberg 17

Tubingen, 72070,

Germany

49 707179490

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.